Skip to content
OpenCapital
Get started

Proto Labs PRLB Add - Incremental shares under stock-based compensation plans (in shares)

Add - Incremental shares under stock-based compensation plans (in shares) at other companies

Kennametal logo
KennametalKMT
——
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
——

Other financials

Income statement

See full
Revenue$139.3M+10.4%
Gross profit$63.6M+14.2%
Operating income$9.8M+117%
Net income$8.1M+125%
EPS (diluted)$0.33+120%

Balance sheet

See full
Cash & equivalents$124.0M+49.9%
Total debt$2.6M-16.6%
Total equity$683.1M+4.0%
Total assets$778.6M+5.6%

Cash flow

See full
Operating cash flow$17.5M-4.6%
CapEx$3.5M+181%
Free cash flow$14.0M-18.2%

Valuation

See full
Market cap$1.9B+59.7%
Enterprise value$1.78B+60.4%
P/E73.7×-3.9×
P/S3.5×+1.1×

Profitability

See full
Gross margin44.9%+0.5pp
Operating margin5.6%+1.7pp
Net margin4.7%+1.6pp
FCF margin10.4%-3.1pp

Returns & leverage

See full
Return on equity3.8%+1.6pp
Debt / equity0×0.0×
Current ratio3.5×+0.4×

Where this comes from

Reported directly by Proto Labs in its filing.

Tagged under the XBRL concept us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements.

The official record: Proto Labs’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Proto Labs's add - incremental shares under stock-based compensation plans (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Proto Labs's add - incremental shares under stock-based compensation plans (in shares)?
Proto Labs (PRLB) reported add - incremental shares under stock-based compensation plans (in shares) of $451.65K in Q1 2026.
How has Proto Labs's add - incremental shares under stock-based compensation plans (in shares) changed year-over-year?
Proto Labs's add - incremental shares under stock-based compensation plans (in shares) increased by 50.3% year-over-year, from $300.52K to $451.65K.
What is the long-term trend for Proto Labs's add - incremental shares under stock-based compensation plans (in shares)?
Over 3 years (2022 to 2025), Proto Labs's add - incremental shares under stock-based compensation plans (in shares) has grown at a 419.6% compound annual growth rate (CAGR), from $6.06K to $850.49K.